House Energy and Commerce Committee Republicans today advanced seven solutions during a Subcommittee on Health markup.

“I’m proud this committee is building on its rich, bipartisan history to come together on important priorities for the American people. The legislation we are considering today will help lower costs for Americans and provide more health care price transparency, responsibly fund community health centers and diabetes research, prevent harmful cuts to hospitals that serve the most vulnerable patients, train more doctors in our communities, and improve FDA’s review of animal drugs used by farmers and pet owners,” said Chair Cathy McMorris Rodgers (R-WA) during her opening remarks. “The Energy and Commerce Committee will continue to plow the hard ground on the most important issues before us as a nation, and that certainly includes making sure people can find the care they need at a price they can afford.” 

The Subcommittee on Health took action on the following bills:  

• H.R. 1418, the Animal Drug User Fee Amendments of 2023, led by Rep. Greg Pence (R-IN), was forwarded by the subcommittee to the full committee, as amended, by a 29-0 bipartisan roll call vote. 
• H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act, led by Rep. Larry Bucshon (R-IN), was forwarded by the subcommittee to the full committee, without amendment, by a 28-0 bipartisan roll call vote.
• H.R. 3281, the Transparent PRICE Act, led by Chair Rodgers, was forwarded by the subcommittee to the full committee, as amended, by a 27-0 bipartisan roll call vote. 
• H.R. 2666, the Medicaid VBPs for Patients (MVP) Act, led by Rep. Brett Guthrie (R-KY) was forwarded by the subcommittee to the full committee, as amended, by a 16-11 bipartisan roll call vote.
• H.R. 3285, the Fairness for Patient Medications Act, led by Rep. Morgan Griffith (R-VA), was forwarded by the subcommittee to the full committee, without amendment, by a voice vote.
• H.R. 3284, the Providers and Payers COMPETE Act, led by Rep. Michael Burgess (R-TX), was forwarded by the subcommittee to the full committee, without amendment, by a bipartisan 27-0 roll call vote.
• H.R. 3290, to amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program, led by Rep. Larry Bucshon (R-IN), was forwarded by the subcommittee to the full committee, without amendment, by a 16-12 roll call vote.

Note: Many of the bills originally noticed were included in an Amendment in Nature of the Substitute to H.R. 3281.